Retroviral vectors
暂无分享,去创建一个
[1] A. Rein,et al. Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70SU , 1992, Journal of virology.
[2] A. Miller. Retrovirus packaging cells. , 1990, Human gene therapy.
[3] A. Miller,et al. Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice , 1993 .
[4] D. Kabat,et al. Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[5] Richard A. Morgan,et al. Gene Therapy for Infectious Diseases , 1998, Clinical Microbiology Reviews.
[6] W F Anderson,et al. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. , 1993, Human gene therapy.
[7] S. Russell,et al. Gene transfer technologies for the gene therapy of cancer. , 1994, Gene therapy.
[8] D. Littman,et al. Packaging system for rapid production of murine leukemia virus vectors with variable tropism , 1992, Journal of virology.
[9] K. Cornetta,et al. Analysis of retroviral packaging lines for generation of replication-competent virus. , 1990, Virology.
[10] F. Cosset,et al. Packaging cells for avian leukosis virus-based vectors with various host ranges , 1992, Journal of virology.
[11] D. Cosman,et al. Stably transmitted triple-promoter retroviral vectors and their use in transformation of primary mammalian cells , 1988, Molecular and cellular biology.
[12] R. Vile,et al. Identification of a generalised packaging sequence for D-type retroviruses and generation of a D-type retroviral vector. , 1992, Virology.
[13] C. Southam. DIVISION OF MICROBIOLOGY: PRESENT STATUS OF ONCOLYTIC VIRUS STUDIES* , 1960 .
[14] J. Roth,et al. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. , 1993, Cancer research.
[15] F. Jensen,et al. Human serum lyses RNA tumour viruses , 1975, Nature.
[16] W. Anderson,et al. Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins , 1993, Journal of virology.
[17] A. Miller,et al. Human gene therapy comes of age , 1992, Nature.
[18] M. Emerman,et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells , 1993, Nature.
[19] S. Russell. Replicating vectors for cancer therapy: a question of strategy. , 1994, Seminars in cancer biology.
[20] A. Panganiban,et al. Ordered interstrand and intrastrand DNA transfer during reverse transcription. , 1988, Science.
[21] F. Collins,et al. Cystic fibrosis: molecular biology and therapeutic implications. , 1992, Science.
[22] M. Hatzoglou,et al. Hormonal control of interacting promoters introduced into cells by retroviruses. , 1991, The Journal of biological chemistry.
[23] R. Ramesh,et al. Biology of disease: The biology of cancer gene therapy , 1995 .
[24] K. Cornetta,et al. No retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic retrovirus. , 1991, Human gene therapy.
[25] Melchner,et al. Identification of cellular promoters by using a retrovirus promoter trap , 1989, Journal of virology.
[26] K. Cornetta,et al. Amphotropic murine leukemia retrovirus is not an acute pathogen for primates. , 1990, Human gene therapy.
[27] A. Wynshaw-Boris,et al. Hepatic gene transfer in animals using retroviruses containing the promoter from the gene for phosphoenolpyruvate carboxykinase. , 1990, The Journal of biological chemistry.
[28] J. Stephenson. Molecular biology of RNA tumor viruses , 1980 .
[29] M. Nicolson,et al. Replication-defective chimeric helper proviruses and factors affecting generation of competent virus: expression of Moloney murine leukemia virus structural genes via the metallothionein promoter , 1987, Molecular and cellular biology.
[30] D. Baltimore,et al. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus , 1983, Cell.
[31] E. Jaffee,et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[32] H. Temin,et al. The terminal nucleotides of retrovirus DNA are required for integration but not virus production , 1983, Nature.
[33] R. Mulligan,et al. The basic science of gene therapy. , 1993, Science.
[34] S. Hughes,et al. Appropriate in vivo expression of a muscle-specific promoter by using avian retroviral vectors for gene transfer [corrected] , 1992, Journal of virology.
[35] T. Friedmann. Gene therapy of cancer through restoration of tumor‐suppressor functions? , 1992, Cancer.
[36] C. Cepko,et al. Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[37] R. Mulligan,et al. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[38] B. Sullenger,et al. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[39] H. Temin,et al. New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors , 1989, Journal of virology.
[40] S. Eccles,et al. Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL‐2 cDNA , 1991, International journal of cancer.
[41] O. Danos,et al. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses , 1992, Journal of virology.
[42] R. Kerbel,et al. Retroviral insertional mutagenesis as a strategy for the identification of genes associated with cis-diamminedichloroplatinum(II) resistance. , 1995, Cancer research.
[43] R. Martuza,et al. Gene therapy of maliganant brain tumors: A rat glioma line bearing the herpes simplex virus type 1‐thymidine kinase gene and wild type retrovirus kills other tumor cells , 1992, Journal of neuroscience research.
[44] R. Scharfmann,et al. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[45] S. Russell,et al. Immunity to B16 melanoma in mice immunized with IL‐2‐secreting allogeneic mouse fibroblasts expressing melanoma‐associated antigens , 1992, International journal of cancer.
[46] H. Temin,et al. High mutation rate of a spleen necrosis virus-based retrovirus vector , 1986, Molecular and cellular biology.
[47] S. Russell. Gene therapy for cancer , 1992, The Lancet.
[48] Z. Ram,et al. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. , 1993, Journal of neurosurgery.
[49] E. Gilboa,et al. Gene therapy for infectious diseases: the AIDS model. , 1994, Trends in genetics : TIG.
[50] R. Weiss. Cellular Receptors and Viral Glycoproteins Involved in Retrovirus Entry , 1993 .
[51] M. Roth,et al. A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range , 1992, Journal of virology.
[52] G. Winter,et al. Retroviral vectors displaying functional antibody fragments. , 1993, Nucleic acids research.
[53] T. Asada. Treatment of human cancer with mumps virus , 1974, Cancer.
[54] W. F. Anderson. What about those monkeys that got T-cell lymphoma? , 1993, Human gene therapy.
[55] J. Roth,et al. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct. , 1993, Cancer research.
[56] Y Takeuchi,et al. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell , 1994, Journal of virology.
[57] T Friedmann,et al. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[58] M. Raffeld,et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer , 1992, The Journal of experimental medicine.
[59] M. Emerman,et al. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus , 1994, Journal of virology.
[60] J. Brookfield,et al. Neutralism and selectionism face up to DNA data. , 1994, Trends in genetics : TIG.
[61] R. Vile. Selectable markers for eukaryotic cells. , 1992, Methods in molecular biology.
[62] Y. Ron,et al. A spleen necrosis virus-based retroviral vector which expresses two genes from a dicistronic mRNA. , 1992, Virology.
[63] R. Vile,et al. A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genes. , 1994, Gene therapy.
[64] C. Richards,et al. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[65] S. Hughes,et al. Retroviral reverse transcription and integration: progress and problems. , 1992, Annual review of cell biology.
[66] A. Miller,et al. Internal initiation of translation in retroviral vectors carrying picornavirus 5' nontranslated regions , 1991, Journal of virology.
[67] R. Edwards,et al. Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[68] N. Dillon. Regulating gene expression in gene therapy. , 1993, Trends in biotechnology.
[69] J. Roth,et al. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. , 1994, Journal of the National Cancer Institute.
[70] D. Pennington,et al. Specific ablation of human immunodeficiency virus Tat-expressing cells by conditionally toxic retroviruses. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[71] M. Bender,et al. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region , 1987, Journal of virology.
[72] A. Miller,et al. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production , 1986, Molecular and cellular biology.
[73] S. Goff,et al. A safe packaging line for gene transfer: separating viral genes on two different plasmids , 1988, Journal of virology.
[74] A. Davison,et al. Molecular virology: a practical approach , 1993 .
[75] E. Gilboa,et al. A pilot study of immunization with HLA-A2 matched allogeneic melanoma cells that secrete interleukin-2 in patients with metastatic melanoma. , 1992, Human gene therapy.
[76] H. Temin,et al. Recent advances in retrovirus vector technology. , 1993, Current opinion in genetics & development.
[77] O. Elroy-Stein,et al. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. , 1992, Nucleic acids research.
[78] K. Cornetta,et al. Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. , 1990, The New England journal of medicine.
[79] A. Miller,et al. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection , 1990, Molecular and cellular biology.
[80] K. Sikora,et al. Gene therapy for cancer using tumour-specific prodrug activation. , 1994, Gene therapy.
[81] T. Palmer,et al. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[82] A. Chang,et al. Immunotherapy of malignancy by in vivo gene transfer into tumors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[83] D. Housman,et al. A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes , 1992, Journal of virology.
[84] J. Yee,et al. Gene expression from transcriptionally disabled retroviral vectors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[85] M. Emerman,et al. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism , 1984, Cell.
[86] R. Vile,et al. Targeted vectors for gene therapy , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[87] C. Richards,et al. Generation of a transgenic model for retrovirus-mediated gene therapy for hepatocellular carcinoma is thwarted by the lack of transgene expression. , 1993, Human gene therapy.
[88] Z. Ram,et al. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. , 1993, Cancer research.
[89] H. Land,et al. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.
[90] Z. Ram,et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. , 1992, Science.
[91] F. Marshall,et al. High efficiency gene transfer into primary human tumor explants without cell selection. , 1993, Cancer research.
[92] C. Higgins,et al. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy , 1993, Nature.
[93] T. Dupressoir,et al. Inhibition by parvovirus H-1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells. , 1989, Cancer research.
[94] A. Panganiban,et al. Human immunodeficiency virus vectors for inducible expression of foreign genes , 1992, Journal of virology.
[95] S. Carillo,et al. The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker. , 1992, The Journal of general virology.
[96] H. Varmus,et al. Efficient incorporation of human CD4 protein into avian leukosis virus particles. , 1990, Science.
[97] S. Rosenberg,et al. The Development of Gene Therapy for the Treatment of Cancer , 1993, Annals of surgery.
[98] R. Vile,et al. Retroviruses as vectors. , 1995, British medical bulletin.
[99] K. Cornetta. SAFETY ASPECTS OF GENE THERAPY , 1992, British journal of haematology.
[100] P. Bruggen,et al. Molecular definition of tumor antigens recognized by T lymphocytes. , 1992 .
[101] J. Cunningham,et al. Human cells infected with retrovirus vectors acquire an endogenous murine provirus , 1990, Journal of virology.
[102] Flügel Rm. Spumaviruses: a group of complex retroviruses. , 1991 .
[103] R. Mulligan,et al. Lineage-specific expression of a human β-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells , 1988, Nature.
[104] L. Cupples,et al. A model for predicting the risk of cancer consequent to retroviral gene therapy. , 1992, Human gene therapy.
[105] K. Harbers,et al. Retroviral integration sites in transgenic Mov mice frequently map in the vicinity of transcribed DNA regions , 1990, Journal of virology.
[106] Philippe Soriano,et al. Promoter interactions in retrovirus vectors introduced into fibroblasts and embryonic stem cells , 1991, Journal of virology.
[107] J. Coffin,et al. Highly preferred targets for retrovirus integration , 1988, Cell.
[108] Brian Salmons,et al. Targeting of retroviral vectors for gene therapy. , 1993, Human gene therapy.
[109] Joseph Zabner,et al. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis , 1993, Cell.
[110] Y. Ron,et al. High rate of genetic rearrangement during replication of a Moloney murine leukemia virus-based vector , 1993, Journal of virology.
[111] E. Gilboa,et al. Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors. , 1992, Human gene therapy.